<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/F301B8F5-1EAE-4779-8100-0CA59C0DE84A"><gtr:id>F301B8F5-1EAE-4779-8100-0CA59C0DE84A</gtr:id><gtr:name>Accentus Cardiac Ltd</gtr:name><gtr:address><gtr:line1>LIFE SCIENCES HUBWALES 2ND FLOOR 3 ASSEMBLY SQUARE , CARDIFF BAY</gtr:line1><gtr:city>CARDIFF</gtr:city><gtr:postCode>CF10 4PL</gtr:postCode><gtr:region>Wales</gtr:region></gtr:address><gtr:typeInd>P</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F301B8F5-1EAE-4779-8100-0CA59C0DE84A" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>F301B8F5-1EAE-4779-8100-0CA59C0DE84A</gtr:id><gtr:name>Accentus Cardiac Ltd</gtr:name><gtr:address><gtr:line1>LIFE SCIENCES HUBWALES 2ND FLOOR 3 ASSEMBLY SQUARE , CARDIFF BAY</gtr:line1><gtr:city>CARDIFF</gtr:city><gtr:postCode>CF10 4PL</gtr:postCode><gtr:region>Wales</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_PARTICIPANT</gtr:name></gtr:role><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>149210.0</gtr:offerGrant><gtr:projectCost>249348.0</gtr:projectCost></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/28DDCB3F-8B2F-4050-A6F9-6397FA4DEA13"><gtr:id>28DDCB3F-8B2F-4050-A6F9-6397FA4DEA13</gtr:id><gtr:firstName>Philip</gtr:firstName><gtr:surname>Agg</gtr:surname><gtr:roles><gtr:role><gtr:name>PROJECT_MANAGER</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=102341"><gtr:id>240BE6B8-C4DA-4ADC-B930-B98904BFE4F7</gtr:id><gtr:title>Clinical Proof of Concept of Agluna Silver Antimicrobial Cardiac Pacemakers</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Launchpad</gtr:grantCategory><gtr:grantReference>102341</gtr:grantReference><gtr:abstractText>This project will target development of a pacemaker device treated with Agluna&amp;reg; silver ion antimicrobial surface technology. A parallel development will target a biocompatible, anti-microbial surface on a novel cardiac device. The project will catalyse development of Accentus Cardiac within the South Wales medtech cluster.</gtr:abstractText><gtr:fund><gtr:end>2017-12-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/E18E2F0F-AC7D-4E02-9559-669F7C8FEC74"><gtr:id>E18E2F0F-AC7D-4E02-9559-669F7C8FEC74</gtr:id><gtr:name>Innovate UK</gtr:name></gtr:funder><gtr:start>2015-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>149210</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">102341</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>